Drug intelligence / Profile preview

ethinyl estradiol + levonorgestrel (Corium)

Development stage
Unknown
Lead developer
Insud Pharma
Modality
Small Molecules
Administration
Transdermal
01

Overview

AG200 (specifically AG200-15, marketed as Twirla) is a combined hormonal contraceptive (CHC) transdermal patch developed by Agile Therapeutics in collaboration with Corium. It delivers a daily dose of the estrogen ethinyl estradiol and the progestin levonorgestrel. The patch utilizes the proprietary SKINFUSION technology, a multi-layer drug-in-adhesive system designed to deliver hormones through the skin over a seven-day period. AG200 works primarily by suppressing gonadotropins, which inhibits ovulation and thickens cervical mucus to prevent pregnancy. It was FDA-approved in 2020 for use in women of reproductive potential with a BMI < 30 kg/m². Additional pipeline variations include AG200-ER for extended-cycle regimens and AG200-15 (SmP) for shorter, lighter periods.

Brand names
Twirla
Other names
AG200-15 TCDSAG-200-15 TCDSAG 200-15 TCDS
02

Targets

ER (Estrogen receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on ethinyl estradiol + levonorgestrel (Corium).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethinyl estradiol + levonorgestrel (Corium).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call